Global Drug Survey (GDS) runs the world’s largest drug survey. GDS is comprised of a network of international experts in the field of drugs, health, epidemiology and public policy. GDS uses an encrypted, online survey platform to conduct annual anonymous surveys. Over the last 6 years over 550,000 people have taken part in our surveys.
Now in its 8th year, our latest survey GDS2019 which launches in November 2018, will be translated into 23 languages with partners in over 35 countries. Partnering with global media and news networks from across the globe and working with harm reduction organisations and the entertainment industry, GDS focuses on issues that are often ignored by traditional research organisations and government funded centres.
Because we are independent we are free to explore issues of relevance to people to use drugs and can focus our attention on achieving our mission of making drug use safer regardless of the legal status of the drug. All our research is approved by university ethics committees and to date has led to 50 peer reviewed publications in the last 6 years.